Jill, 38 | Stage III breast cancer
Our network answered Jill’s questions, helping her better understand her diagnosis and treatment options. We can help you, too.
It takes just one story to inspire or save a life.
That story could be yours.
Tap the Network’s knowledge, expertise, and resources. Help transform cancer research and clinical care.
We need you! As a volunteer, you could interact with patients, research treatment options, curate information, write code, or raise funds.
If you’d like to help, contact: email@example.com
Heather lost three close colleagues to cancer in the past year. Each struggled to find treatment options after exhausting standard of care. As a Deloitte partner, Heather knows the power of data sharing and collective intelligence. She recently challenged herself to swim a 10,000 meter butterfly, and raised $25,000 for Cancer Commons.
Newly diagnosed? Undergoing treatment? Searching for a clinical trial?
The KnowledgeBase will help you through the entire process.
Read the latest news for Breast Cancer, Lung Cancer, Melanoma,
Neuroendocrine Tumors, and Prostate Cancer.
Emma Shtivelman, PhD | 20 Jul 2015
Chimeric antigen receptor (CAR) T-cell therapy is a new, immune system-based cancer treatment that has garnered recent media attention.
28 Jul 2015
Heather Rangel is a Deloitte partner and a Cancer Commons Pathfinder donor and volunteer. She heads up Project Shine, in which she works with her extensive network to support Cancer Commons.